PDCD1 and melanoma: Additionally, in melanoma patients treated with anti-PD-1, the gut microbiome of non-responders was enriched with Gram-negative bacteria and lipopolysaccharide synthesis-related microbial genes, and the host genes encoding pro-inflammatory cytokines were more highly expressed in stool specimens from non-responders than in those from responders.